RJA
XBI icon

Raymond James & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Raymond James & Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39,800
Closed -$1.01M – 3889
2020
Q3 		$1.01M Sell
39,800
-2,600
-6% -$291K ﹤0.01% 2174
2020
Q2 		$1.19M Hold
42,400
– – ﹤0.01% 2047
2020
Q1 		$70K Buy
42,400
+100
+0.2% +$8.86K ﹤0.01% 3276
2019
Q4 		$453K Sell
42,300
-400
-0.9% -$34.6K ﹤0.01% 2804
2019
Q3 		$2K Hold
42,700
– – ﹤0.01% 3595
2019
Q2 		$109K Buy
42,700
+1,200
+3% +$102K ﹤0.01% 3396
2019
Q1 		$297K Sell
41,500
-500
-1% -$42.5K ﹤0.01% 2989
2018
Q4 		$15K Buy
42,000
+900
+2% +$72.5K ﹤0.01% 3453
2018
Q3 		$709K Buy
41,100
+200
+0.5% +$19.4K ﹤0.01% 2463
2018
Q2 		$658K Sell
40,900
-900
-2% -$82.7K ﹤0.01% 2497
2018
Q1 		$520K Sell
41,800
-12,400
-23% -$1.13M ﹤0.01% 2549
2017
Q4 		$463K Sell
54,200
-11,100
-17% -$930K ﹤0.01% 2580
2017
Q3 		$601K Buy
65,300
+10,100
+18% +$810K ﹤0.01% 2373
2017
Q2 		$247K Buy
55,200
+3,400
+7% +$241K ﹤0.01% 2856
2017
Q1 		$68K Buy
51,800
+11,100
+27% +$745K ﹤0.01% 3117
2016
Q4 		$13K Buy
40,700
+13,200
+48% +$815K ﹤0.01% 3177
2016
Q3 		$67K Buy
27,500
+5,200
+23% +$322K ﹤0.01% 3055
2016
Q2 		$9K Buy
+22,300
New +$1.22M ﹤0.01% 2970

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Raymond James & Associates's XBI Position: Q3 2024 in Review

Raymond James & Associates increased its State Street SPDR S&P Biotech ETF (XBI) stake by 7.7% in Q3 2024, buying an estimated $2.7M and bringing the position to 383,355 shares worth $37.9M. The position accounts for 0.02% of the portfolio, ranked #543.

Raymond James & Associates first reported a position in XBI in Q2 2013 and has held it in 46 quarters since. The position peaked at $46.5M in Q3 2018. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

  • Raymond James & Associates held 383,355 shares of State Street SPDR S&P Biotech ETF worth $37.9M as of Q3 2024.
  • Raymond James & Associates bought 27,511 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $2.7M.
  • State Street SPDR S&P Biotech ETF made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #543 holding.
  • Raymond James & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's State Street SPDR S&P Biotech ETF position peaked at $46.5M in Q3 2018.
  • 769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.